LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | HG-5-88-01 | 10 | uM | LJP6 | 3 | A19 | 72 | hr | 1097 | 1676 | 3696 | 0.4534 | 0.2735 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 1097 | 3216 | 3610 | 0.8907 | 0.8697 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 1097 | 3276 | 3713 | 0.8821 | 0.8624 |
BT-20 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 1097 | 3516 | 3696 | 0.9512 | 0.9437 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 1097 | 2706 | 3610 | 0.7495 | 0.6910 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1097 | 2814 | 3713 | 0.7577 | 0.7082 |
BT-20 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1097 | 2868 | 3696 | 0.7759 | 0.7304 |
BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 1097 | 2610 | 3610 | 0.7229 | 0.6558 |
BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 1097 | 2567 | 3713 | 0.6912 | 0.6213 |
BT-20 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 1097 | 2606 | 3696 | 0.7050 | 0.6383 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1097 | 2117 | 3610 | 0.5863 | 0.4659 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1097 | 2075 | 3713 | 0.5587 | 0.4365 |
BT-20 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1097 | 1960 | 3696 | 0.5302 | 0.3925 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 1097 | 1671 | 3610 | 0.4628 | 0.2773 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 1097 | 1484 | 3713 | 0.3996 | 0.1873 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 1097 | 1527 | 3696 | 0.4131 | 0.2076 |
BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 1097 | 657 | 3610 | 0.1820 | -0.2581 |
BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 1097 | 626 | 3713 | 0.1686 | -0.2732 |
BT-20 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 1097 | 598 | 3696 | 0.1618 | -0.2928 |
BT-20 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 1097 | 2621 | 3735 | 0.7017 | 0.6367 |
BT-20 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 1097 | 2956 | 3877 | 0.7623 | 0.7231 |
BT-20 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 1097 | 3103 | 3925 | 0.7905 | 0.7600 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1097 | 2410 | 3735 | 0.6452 | 0.5608 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1097 | 2721 | 3877 | 0.7017 | 0.6465 |
BT-20 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 1097 | 2749 | 3925 | 0.7003 | 0.6478 |